Jennifer Essig

VP of Finance at Deciphera Pharmaceuticals

Speaker

Jenn is VP of Finance of Deciphera Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. Deciphera became a member of Ono Pharmaceutical Co., Ltd. in June 2024. At Deciphera, Jenn is responsible for the oversight of the accounting, financial reporting, J-SOX, finance operations, finance systems, FP&A, and procurement teams. Jenn joined Deciphera in 2019 as Director, Corporate Controller.

Prior to her time at Deciphera, Jenn was Associate Director, Corporate Accounting at Biogen, for over 7 ½ years, where she was responsible for the close to SEC reporting process. Jenn started her career at PricewaterhouseCoopers and included a range of clients from the life sciences industry.

Jenn has a Master’s Degree in Accounting from Northeastern University and a Bachelor’s Degree in Accounting from Stonehill College.